CCN2
CCN family member 2
Also known as: CCN2_HUMAN, CTGF, IGFBP8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29279
- Gene
- CCN2
- Ensembl
- ENSG00000118523
- Chromosome
- 6
- Canonical length
- 349 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus,Vesicles
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis. [provided by RefSeq, Nov 2009]
Canonical amino-acid sequenceUniProt
349 residues, UniProt reviewed canonical sequence.
>P29279|CCN2
1 MTAASMGPVR VAFVVLLALC SRPAVGQNCS GPCRCPDEPA PRCPAGVSLV LDGCGCCRVC
61 AKQLGELCTE RDPCDPHKGL FCHFGSPANR KIGVCTAKDG APCIFGGTVY RSGESFQSSC
121 KYQCTCLDGA VGCMPLCSMD VRLPSPDCPF PRRVKLPGKC CEEWVCDEPK DQTVVGPALA
181 AYRLEDTFGP DPTMIRANCL VQTTEWSACS KTCGMGISTR VTNDNASCRL EKQSRLCMVR
241 PCEADLEENI KKGKKCIRTP KISKPIKFEL SGCTSMKTYR AKFCGVCTDG RCCTPHRTTT
301 LPVEFKCPDG EVMKKNMMFI KTCACHYNCP GDNDIFESLY YRKMYGDMALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 1,230 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 1,230 nTPM
- smooth muscle: 538 nTPM
- spleen: 537 nTPM
- cervix: 498 nTPM
- thyroid gland: 436 nTPM
- gallbladder: 413 nTPM
Single-cell type
- hepatic stellate cells: 2,033 nCPM
- podocytes: 980 nCPM
- pancreatic duct cells: 628 nCPM
- endometrial ciliated cells: 523 nCPM
- peritubular myoid cells: 439 nCPM
- vascular endothelial cells: 413 nCPM
Immune cell
- naive B-cell: 8.1 nTPM
- memory B-cell: 1.1 nTPM
- total PBMC: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- midbrain: 53 nTPM
- choroid plexus: 51 nTPM
- cerebral cortex: 38 nTPM
- thalamus: 29 nTPM
- hippocampal formation: 28 nTPM
- pons: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CCN2.
Disease | AllUniProt
Conditions CCN2 is implicated in, by any mechanism.
- Kyphomelic dysplasia (KMD) MIM:211350
- Spondyloepimetaphyseal dysplasia, Li-Shao-Li type (SEMDLSL) MIM:621099
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 64 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Kyphomelic dysplasia
- Spondyloepimetaphyseal dysplasia, Li-Shao-Li type
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cartilage condensation
- cell adhesion
- cell migration
- cell-matrix adhesion
- chondrocyte differentiation
- chondrocyte proliferation
- DNA biosynthetic process
- epidermis development
- fibroblast growth factor receptor signaling pathway
- integrin-mediated signaling pathway
- lung development
- negative regulation of gene expression
- osteoblast differentiation
- positive regulation of cell differentiation
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of JNK cascade
- positive regulation of stress fiber assembly
- reactive oxygen species metabolic process
- regulation of chondrocyte differentiation
- response to wounding
- signal transduction
- tissue homeostasis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Insulin-like growth factor-binding protein, IGFBP
- Thrombospondin type-1 (TSP1) repeat
- VWFC domain
- Cystine knot, C-terminal
- Glycoprotein hormone subunit beta
- Growth factor receptor cysteine-rich domain superfamily
- IGFBP-related, CNN
- Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site
- Thrombospondin type-1 repeat superfamily
- CCN, TSP1 domain
- Cellular Communication Network Factor
- Cystine-knot domain
- von Willebrand factor type C domain
- Insulin-like growth factor binding protein
- CCN3 Nov like TSP1 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCN2 as an antibody target. Whether an autoantibody or antibody against CCN2 could matter depends on whether native CCN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCN2 is annotated as secreted, so native CCN2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CCN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...